INTRODUCTION
Upper gastrointestinal bleeding/haemorrhage (UGIB/UGIH) has been the most frequently encountered and life-threatening emergency with which patients present to the hospital and carries a substantial patient morbidity and mortality. 1 The GI tract is divided into an upper and lower part by the presence of ligament of Treitz, a peritoneal fold suspending the duodenojejunal flexure. It thus becomes a landmark to categorize extensive GI tract. The source of UGIB lies somewhere proximal to the ligament of Treitz while that of lower GI bleed lies distal to the ligament of Treitz. 2 Though this division is not exclusive to localize the source of bleeding, but it guides from where to start investigating a patient. 3 There are DOI: 10 .29309/TPMJ/2019. 26.11.3224 Professional Med J 2019;26 (11) : 1916-1924. www.theprofesional.com UPPER GI BLEEDING 1917 2 many causes of upper GI bleed; few illustrations include esophageal varices with or without portal hypertension, peptic ulcer disease, gastritis, oesophagitis, duodenitis, upper GI malignancies, Mallory-Weiss tears, angiodysplasia, uremia, haemobilia or coagulation disorders. 4, 5 but the two most common causes encountered in our region are bleeds due to oesophageal varices and peptic ulcer disease. 5 Broadly UGIB is categorized into two main types, i.e. variceal and non-variceal bleed, both carrying different intervention and prognosis. Acute variceal haemorrhage (AVH) is a major complication of portal hypertension occurring in almost 30% of patients with cirrhosis and accounting for 80-90% of bleeding episodes in these patients. 6 Studies highlight Hepatitis as a major culprit of cirrhosis with Hepatitis C Virus (HCV) causing 41-52%, followed by Hepatitis B Virus (HBV) causing 30% of the cases 7 with a mortality rate of 11-50%. 1 In contrast, non-variceal upper gastro-intestinal haemorrhage (NVUGIH) is most often caused by erosive gastritis and peptic ulcer disease-NSAID intake and H.Pylori infection being at the top of the causative factors of ulcer disease 8 with an overall mortality rate of around 3-14% which is far lesser than the AVH. 1 UGIB can present in various ways. Though the most common symptoms of patients are melena, blood in vomitus either fresh (hematemesis) or altered blackish clots (coffee-ground emesis), hematochezia (fresh blood per rectum) or sometimes just land with iron-deficiency anemia having microscopic fecal bleed loss. 5, 9 The most appropriate step taken at that time in the management of patient is to perform an endoscopy as soon as possible which is a primary therapeutic and diagnostic modality that allows to evaluate the cause of UGIB and to control the bleed with various endoscopic measures as well. 10 According to the current international guidelines, upper GI endoscopy should be performed within 24 hours of patient presentation which appears to be more helpful in guiding further intervention and reducing the need for prolonged hospitalization. 11 Endoscopy has played a very vital role in emergent management of patient. Over the last 20 years, many dramatic changes have been made in the management strategies of UGIB including the introduction of acid suppressive therapy and endoscopic haemostasis which has decreased the need for surgical interventions, but despite all those advancements, mortality rate remained relatively unchanged of about 6-13%, accounted in most studies. 12 Numerous studies support the fact that majority of deaths do not result from failure of medical or surgical interventions but from comorbidities, poorly tolerated severe blood loss and resultant complications of the underlying etiology. 13 According to various studies, factors significantly influencing the mortality in patients presenting with UGIB were increasing age, presence of co-morbidities (diabetes mellitus, hypertension, ischemic heart disease, chronic renal failure), systolic blood pressure <100 mm Hg, advanced Child-Pugh score, presence of hepatic encephalopathy, hepatocellular carcinoma, hemoglobin <10 g/dL, international normalized ratio (INR) > 1·6, serum creatinine > 2·0 mg and early re-bleeding after endoscopy. 6, 7, 10 Rebleeding, occurring in approximately 10-30% of cases, is also considered an important hazard of uprising mortality. 14 The rationale of our study is to determine the etiological patterns of UGIB and common factors involved in morbidity and mortality of the patients because this data in context of our population is important to take more careful preventive measures and improve management tactics.
METHODOLOGY
A descriptive analytical study was conducted on a total of 260 patients including both males and females from 12 to 85 years of age, presented in the Medicine department of Civil Hospital Karachi. The project continued from January 2018 to June 2018. All referred in-patients, out-patients and ones who landed in the emergency department with complaint of upper GI bleed (hematemesis, melena and hematochezia) were included in the study. The participants were followed for up to 2 weeks to evaluate the risk factors that increase the morbidity and mortality of patients. UPPER GI BLEEDING 1918 3 After initial hemodynamic stabilization of patients in the emergency department with crystalloids, blood or blood products (if necessary), intravenous proton pump inhibitors and intravenous vasoconstrictor; Octreotide (if known underlying liver pathology with high suspicions of having variceal bleed), upper GI endoscopies were performed by experienced endoscopists in our endoscopy suite. A formal written consent was obtained from every patient for contributing in the study. Saeed's six shooter band ligator was used for esophageal varices and injection histoacryl and lipiodol were used for obliteration of fundal varices while injection diluted adrenaline 1:10000 heater probe and hemoclips were used for non-variceal bleed.
After endoscopy, patients were shifted to their primary ward for further evaluation and were discharged afterwards depending upon their vital status and well-being. Data of all participated patients were collected in a standardized and detailed way including mode of presentation, any ongoing illness (especially gastric or liver diseases), coexisting illnesses, history of previous hospital admission, drug history, thorough examination findings, baseline blood and radiological investigations, medical treatment given initially, endoscopic results, incidence of rebleeding, need for transfusion before or after endoscopy and cause of death (if occurred so). The whole multivariate analysis was then used to get Rockall score of individual patients. Rockall system is one of the several risk analysing tools used to stratify risk of mortality of patients with UGIB by classifying them into low, moderate or high-risk group. 15 The parameters of Rockall scoring system include three clinical variables (age, shock, and comorbidity) and two endoscopic variables (diagnosis and major SRH). It classifies patients into three categories on the basis of individual calculated score which is: score < 3 are low risk, score of 3-4 are moderate risk and > 4 are high risk patients. 16 After calculation, an association between Rockall score and patient's outcome (morbidity and mortality) was assessed. The data collected was analysed by using SPSS version 22·0.
Inclusion and Exclusion Criteria
We included adult male and pregnant and nonpregnant female patients aged ≥ 12 years who presented with upper GI bleed either as a first episode or subsequent episodes of bleed whether recorded as a principal diagnosis at the time of admission or underwent an in-patient bleed, having any other reason of admission. Children were not included. Patients having any other source of bleeding such as from airways were excluded. Patients who did not give consent or those who were not fit for endoscopy were also excluded.
RESULTS
A total of 260 individuals were added in the survey from which 162 (62·3%) were males and 98 (37·7%) were females. Their age ranged between 12 to 85 years from which majority (n=197, 75·8%) of the candidates were less than 60 years. The clinical profile of patients showed that a total of 227 (87·3%) had both hematemesis and melena while remaining 33 (12·7%) had non-specific symptoms (symptoms of anemia, hematochezia or fecal occult blood). Only 147 (56·5%) patients gave a significant history of previous hospital admission with the same complain. In the study, oesophago-gastro-duodenoscopy (OGD) extracted varices (esophageal or fundal) with evident portal hypertension in 186 (71·5%) patients as the most common lesion for bleeding. Among those 186 patients, 134 were diagnosed cases of hepatitis C -being the most common leading cause of varices, and 35 suffered from hepatitis B. However, 13 patients had no proven history of such viral infections (sero-negative) but still had variceal bleed. On the other hand, rest of the 74 (28·4%) patients had non-variceal etiology of bleed; peptic ulcer disease accounted as the most common etiology of that. (Figure-1) The possible risk factors of non-survivors contributing in their mortality are given in Table-II. Furthermore, in our study, a good correlation is made in between Rockall score and mortality of a patient. (Table-III till 3, moderate risk (group 2) who scored 3-4 and high risk (group 3) who scored > 4. It was seen that majority of the patients who died belonged to group 3 (high risk) with a Rockall score > 4. At significance level 95%, the p-value for Rockall score and patient's outcome was 0·000 (or less than 0.001 according to NEJM0) which is statistically significant. Hence, the greater the Rockall score, greater would be the morbidity and mortality of a patient. 20 In contrast, peptic ulcer disease-a non-variceal lesion of bleed has appeared to be the most common cause in western sides, occurring secondarily to H.pylori infection or NSAIDS. 17 According to the statistics of the United States, more than 350,000 patients get hospitalized annually with UGIB 4 having mortality rates of 5% to 11%. 10 According to a research, the mortality of esophageal or fundal variceal bleed in patients with underlying cirrhosis had been reported to be as high as 50% 18 whereas mortality of non-variceal bleed had reached to 10-14%. 19 Although more recent data elucidates that use of more potent vasoactive drugs, advent of various endoscopic measures and surgical procedures have played a pivotal role in reducing mortality rates of variceal bleed to 20% 18 and of non-variceal bleed to 3·8-5·6% 21 but still they are on the higher side. Hence, the mortality of GI bleeding has not decreased much during the past 50 years.
Outcome

Number of Patients
Many researches have been done to enlighten the clinical and endoscopic profile of patients suffering from UGIB, but very limited data is available to evaluate the factors associated with mortality of such patients, specifically in our region. Therefore, this study was designed to identify the most common causes leading to UGIB and illuminate some of the important factors increasing the morbidity and mortality of patients presenting to our hospital.
According to some previous researches, geriatric population has a very high incidence of UGIB with poor outcome. This could be supported by the fact that older people have more comorbid and many of them are chronic NSAIDS users, both of them predispose to bleed. 22 In a study done by Mahajan et al 23 , a greater number of population who presented with UGIB belonged to elderly group, most of them having comorbid conditions. Similarly, in the present study, more than fifty percent of the patients were in their fifth or sixth decade having certain comorbid (diabetes mellitus, hypertension, ischemic heart disease or renal failure) which significantly increased the fraction of death.
In our study, out of 260 patients, 62·3% were males while only 37·7% were females who came with complain of UGIB which gives an idea that UGIB is more common in males than their counter partners. An Indian study done by Anand et al. 10 also showed similarity with the current one in which the ratio of male to female bleeders 26 also found peptic ulcer disease as the most frequent reason for UGIB followed by varices and erosive disease. In contrast, according to the result of our research, variceal bleed was found to be the most common pathological lesion leading to UGIB, with 54·62% of population reported to have esophageal varices with portal hypertensive gastropathy and 14·3% had fundal varices. Peptic ulcer disease which was encountered in 7·7% of patients remained the next common cause of UGIB. This finding of ours coincided with a study done in Egypt by Elsebay et al. in which more than half of the patients were diagnosed with variceal cause of upper GI bleed. 27 A recent study in Nepal also contracted the same etiology in upper GI bleeders. 28 This difference in pattern might be due to a great prevalence of infectious liver diseases; like hepatitis B and hepatitis C in Asian regions which are one of the common reasons of chronic liver disease leading to portal hypertension and variceal bleed. 5 In terms of management of upper gastrointestinal bleeding, upper GI endoscopy is the mainstay of treatment in active bleeders and should be done within 24 hours of presentation of patient to control the bleed and evaluate the cause. 29 According to numerous researches, early endoscopic intervention significantly improves the outcome and reduces patient mortality. 30 But the guidelines provided by the American Society of Gastrointestinal Endoscopy and the American College of Gastroenterology recommend that hemodynamic stabilisation of unstable patients should be prioritized over endoscopic intervention 31 which is done mostly with a sufficient amount of crystalloid infusion and precise monitoring of vital signs. The same protocol was followed in the emergency department of CHK, where patients initially underwent vital stabilization by various measures like crystalloid or blood infusion (if needed), and then were proceeded for further necessary interventions. Consecutively, pharmacotherapy with antacids (proton pump inhibitors) and vasoactive drugs (sandostatin or terlipressin) are an essential adjunct to endoscopy which reduce further episodes of rebleeding and make subsequent endoscopic intervention easy. 30 Rebleeding and outcome showed a substantial correlation, with rebleeding itself being an independent prognostic factor for mortality. 32 Survey done by Bambha et al. evidenced re-bleeding in 37 (15%) out of 256 patients and showed a significant risk of mortality 6 weeks post-AVH, leaving an adverse effect on overall survival of patients. 33 However, in our study, rebleeding occurred in total of 19 patients (7·3%) with a mortality of 8 patients (3·07%) equally belonging to variceal and non-variceal group of bleeders.
Discoursing the laboratory results of patients, it is said that presenting hemoglobin levels are proportionally related to patient's consequence.
In a research work of Chaikitamnuaychok et al., an Hb of < 10 g/dL and systolic blood pressure of < 100 mmHg at presentation were considered one of the indicators of a noticeable increase in mortality. 34 Similarly, in the present study, patients with Hb < 10 g/dL (n=12) and those who were hypotensive at the initial occasion (n=8) died more than those having normal hemoglobin or mild anemia. In correspondence to it, a disturbed INR and impaired renal function were also predictively significant. According to a study of Deep Anand et al., an international normalized ratio (INR) of > 1·6 10 contained high mortality which is favoured by the results of current study in which 8 patients with disturbed INR had worse outcome than rest. Moreover, he also added that serum creatinine > 2·0 mg/dL 10 was seen most commonly in nonsurvivors than in survivors. Though this feature contradicts with the result extracted in our study in which majority of non-survivors (n=9) had creatinine in normal limits while only 2 deceased patients had serum creatinine > 2·0 mg/dL when they landed in the hospital. Nevertheless, such laboratory results are indispensable and should be put into consideration in determining risk of mortality.
The analysis of patients was done by calculating Rockall score of them. This is basically an assessment algorithm which consists of few variables including clinical criteria and endoscopy results to classify bleeders into low, moderate and high-risk categories and approximate the risks of mortality. 16 It is evidenced that mortality increases in a stepwise fashion as the risk score increases.
The result of our study coincides with the concept as majority of deaths occurred in patients who belonged to high-risk group having cumulative score of > 4. This finding absolutely accords with the results of Phang et al. in which patient mortality was high with rockall score > 4. 35 Overall mortality of our study was 5·76% (15 out of 260 patients expired), out of which 11 (4·2%) patients expired from variceal group of UGIB, 3 (1·1%) patients due to ulcer disease and 1 (0·38%) patient with gastric malignancy which proved that varices carry higher mortality ration as compared to other non-variceal causes of bleeding.
LIMITATIONS
Several limitations are encountered in this study. Firstly, there are various scoring systems that have been used nowadays for classification and for intervention but unfortunately, the complexity of these scoring systems limits their use in routine practice. Secondly, due to the government setup and heavy patient load, we are unable to perform endoscopy within 24 hours of patient admission which is followed world-wide. That's why patients are managed initially by conservative measures and then are enlisted for endoscopy which might have taken days and even weeks from their first presentation. This hinders the accurate diagnosis most of the times and may play a role in deteriorating the underlying disease and to patient's death.
RECOMMENDATIONS
Early upper GI endoscopy (within 24 hours of presentation) is recommended in all bleeders because it confirms the diagnosis and allows for targeted endoscopic treatment, resulting in reduced morbidity and mortality. 23 Rebleeding is very important and a prompt attention should be taken either endoscopically or surgically as soon as the occurrence of event. It can occur in 10-20% of patients despite successful endoscopic therapy and endoscopy must be attempted once more in such patients. Surgical intervention may be required in patients with severe and persistent bleeding. 23 Apart from that, laboratory work-up should be done in every patient coming with UGIB and values must be put into consideration as they also are profound in predicting mortality.
Hence, further intervention should be planned accordingly to correct the underlying laboratory errors.
CONCLUSION
In this study, variceal bleeding was found as the predominant lesion of upper gastro-intestinal bleeding followed by peptic ulcer disease. Certain factors are found that are strongly related in deteriorating patient's outcome. Along with it, Rockall score is also a good predictor of outcome of patients. Amanullah Abbasi
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